FibroGen, Inc
Company Name: FibroGen, Inc. FibroGen, Inc. is a biopharmaceutical company. The company is engaged in the development and commercialization of therapeutics utilizing fibrosis and hypoxia-inducible factor (HIF) biology. The company’s lead product candidate is a treatment for anemia in chronic kidney disease. Ticker Symbol: FGEN (NASDAQ) Company Website: www.fibrogen.com Social Media: FibroGen LinkedIn Headquarters: San Francisco, CA Publicly Traded … Read more